This is no way

to treat an aorta.

Edwards EZ Glide Aortic Cannula

Featuring Safe-Flo Technology
Edwards EZ Glide Aortic Cannula
Designed for protection.
Built for ease-of-use.
By putting a new level of gentle, dispersive flow into an easy-to-use

cannula, our enhanced EZ Glide aortic cannula helps you protect patients

from the potential dangers of embolic dislodgement. The unique auto-

dilating tip enables fast and easy insertion, while the optimized tip angle

provides centered flow inside the aorta, away from the vessel wall. Our

innovative Safe-Flo tip disperses return flow in a gentle, conical spray

pattern—resulting in lowered exit force and line pressure. All of which

reduces the likelihood of embolic disruption.

Virtually all cardiac surgery patients are at risk of neurologic and end-organ damage from
emboli released during the procedure.1-6

With detectable particulates released in virtually every cardiac surgery,1-6 the prevalence
and potential dangers of emboli have been well documented.2,6,7
Standard
dispersion-tip
cannula

Location and angle of

the tip can focus return
flow directly against
the aortic wall.

Flow direction
not optimal.
The EZ Glide
aortic cannula
with Safe-Flo
technology

Specially designed
auto-dilating tip requires
only a small incision
and eases insertion of
cannula into the aorta.

Central orientation
of the cannula tip is
engineered to reduce
direct jetting of flow
against the aortic wall.

Gentle web-like
dispersion of return
flow is designed to
minimize turbulence
and help reduce the
danger of dislodging
particulate matter
from vessel walls.
Edwards EZ Glide Aortic Cannula Model Numbers
Model No. Size Connector Tip
EZ Glide Cannula Flow Curves
EZS21A 21 Fr. Straight Straight w/suture ring
180
EZS21TA 21 Fr. T-Connector Straight w/suture ring EZS21
160
EZS24A 24 Fr. Straight Straight w/suture ring
140
EZS24TA 24 Fr. T-Connector Straight w/suture ring

Pressure Drop (mmHg)

120
EZC21A 21 Fr. Straight Curved w/suture bump EZC21
100
EZC21TA 21 Fr. T-Connector Curved w/suture bump
EZS24
EZC24A 24 Fr. Straight Curved w/suture bump 80

EZC24TA 24 Fr. T-Connector Curved w/suture bump 60

EZC24
EZF21A 21 Fr. Straight Curved w/suture flange 40

EZF21TA 21 Fr. T-Connector Curved w/suture flange 20

EZF24A 24 Fr. Straight Curved w/suture flange

0
0 1 2 3 4 5 6 7
EZF24TA 24 Fr. T-Connector Curved w/suture flange
Flow rate (L/min) – H 20 at room temperature

References
1. Barbut D, Hinton RB, Szatrowski TP, et al. Cerebral emboli detected during bypass surgery are associated with clamp
removal. Stroke. Dec 1994;25(12):2398-2402. Rx only. See instructions for use for full prescribing information.
2. Barbut D, Lo YW, Gold JP, et al. Impact of embolization during coronary artery bypass grafting on outcome and
length of stay. Ann Thorac Surg. Apr 1997;63(4):998-1002. Edwards Lifesciences devices placed on the European market
3. Bergman P, Hadjinikolaou L, van der Linden J. Aortic atheroma is related to number of particulates captured by meeting the essential requirements referred to in Article 3 of
intra-aortic filtration in CABG. Eur J Cardiothorac Surg. Oct 2002;22(4):539-544. the Medical Device Directive 93/42/EEC bear the CE marking
4. Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass of conformity.
grafting. Genesis and effect on outcome. J Thorac Cardiovasc Surg. Feb 1995;109(2):249-257; discussion 257-258.
5. Hammon JW, Jr., Stump DA, Kon ND, et al. Risk factors and solutions for the development of neurobehavioral Edwards, the stylized E logo, and EZ Glide are trademarks of
changes after coronary artery bypass grafting. Ann Thorac Surg. Jun 1997;63(6):1613-1618. Edwards Lifesciences Corporation. Edwards Lifesciences
6. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. is a trademark of Edwards Lifesciences Corporation and
Feb 8 2000;101(5):570-580. is registered in the U.S. Patent and Trademark Office.
7. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery.
Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation © 2006 Edwards Lifesciences LLC
Investigators. N Engl J Med. Dec 19 1996;335(25):1857-1863. All rights reserved. AR01217

Edwards Lifesciences LLC • One Edwards Way • Irvine, CA 92614 USA • 949.250.2500 • 800.424.3278 • www.edwards.com
Edwards Lifesciences (Canada) • 1290 Central Parkway West, Suite 300 • Mississauga, Ontario • Canada L5C 4R3 • 800.268.3993 • 905.566.4220
Edwards Lifesciences S.A. • Ch. du Glapin 6 • 1162 Saint-Prex • Switzerland • 41.21.823.4300
Edwards Lifesciences Japan • 2-8 Rokubancho • Chiyoda-ku, Tokyo 102-0085 • Japan • 81.3.5213.5700